We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bausch Agrees to Settle Antitrust Lawsuit for $300 Million
Bausch Agrees to Settle Antitrust Lawsuit for $300 Million
Bausch Health has agreed to pay $300 million in cash to settle an antitrust class action on behalf of consumers over the type 2 diabetes drug Glumetza.